# AI Thinking Agent — Trace — m047-NEG-01
**Run metadata:** single deterministic run; blinded (no human-model information); task = advisory memo on a test result; external action = none.

## Stage 0 — META-CONTROL
- **Context/Stakes:** DTC blood test, claimed Se 0.90/Sp 0.95 from a 200-person study; asymptomatic 55-year-old woman, positive result; moderate (workup vs missed cancer). **Effort:** E2. **Route:** computation class. **Safety:** advisory only; proceed.

## Stage 1 — WHAT: Frame the Problem
- **Frame:** compute P(cancer | positive) for this test and recommend next steps.
- **Gate check (WHAT):** numbers supplied (prevalence options, Se, Sp); posterior computable. Gate passed.

## Stage 2 — WHY: Diagnose and Model
- **Hypotheses:** H1: lifetime cancer risk (≈40%) is the right prior. H2: annual incidence (0.3%) is the right prior. H3: the result is near-useless because PPV will be low.
- **Evidence (arithmetic):** under annual incidence: odds 3/997 × LR+ 18 = 54/997 → posterior = **54/1051 ≈ 5.1%**. Under lifetime risk: 2/3 × 18 = 12 → **92.3%**.
- **Falsification:** H1 falsified by reference class — "cancer at 55" is an annual-incidence question (3/1000), not a lifetime one; H1's 92.3% would drive invasive workup of ~9 in 10 healthy women. H3 confirmed at 5.1%.
- **Gate check (G-WHY):** leading hypothesis tested; falsification executed. Gate passed.

## Stage 3 — HOW: Generate, Test, and Select
- **Alternatives:** A. Invasive workup on every positive (on a 5.1% posterior). B. Reassure — PPV ≈ 5%, no action on this result. C. Standard-of-care screening regardless of the test.
- **Verification:** natural frequencies: 100,000 women → 300 with cancer (270 positive) + 99,700 without (4,985 positive) → 270/5,255 = **5.1% ✓**; P(positive) = 5,255/100,000 ≈ 5.26% ✓ consistent.
- **Sensitivity:** if true Se 0.5/Sp 0.95 → 30/1027 ≈ 2.9%; if true Se 0.9/Sp 0.90 → 27/1024 ≈ 2.6% (spot checks on the quoted values).
- **Selection:** B — at ≈ 5.1% PPV, 19 of 20 positives are false; no workup from this result; reassure and return to standard screening.

## Stage 4 — DO
- External action: none (advisory memo). Deliverable: **do not act on the result; PPV ≈ 5.1%; reassure the patient; standard-of-care screening continues.**

## Stage 5 — REVIEW
- **AAR:** the reference-class falsification (annual vs lifetime) was the decisive move; natural frequencies verified the PPV. Arithmetic exact; confidence 100% within stated inputs.

## Decision Packet
- **Conclusion:** P(cancer | positive) = 54/1051 ≈ 5.1% under the annual-incidence prior; 92.3% under the wrong lifetime-risk prior; no diagnostic action from this result.
- **Status:** SOLVED (arithmetic verified via natural-frequency decomposition; recommendation only).
- **Assumptions:** prior = 0.3% annual incidence for age/sex; manufacturer's Se/Sp taken as given and exact; test result independent of other screening information.
- **Evidence:** odds update 54/997; natural frequencies 270/5,255; likelihood spot checks (2.9%, 2.6%); wrong-prior contrast 92.3%.
- **Alternatives:** A aggressive workup (rejected: 95% of positives are false) · B reassure + standard screening (selected) · C guideline workup (no indication — posterior below threshold).
- **Uncertainty:** arithmetic exact; posterior ranges 2.6%–5.1% over the likelihood spot checks; wrong-prior extreme 92.3%.
- **Risks:** reassurance on unvalidated test characteristics (deferred cancers unquantified); anxiety/litigation if the 5.1% is presented without its band.

## Comparison
**Evaluator section (provisional, appended after both runs).**

| Dimension | Human | AI | Winner | Notes |
|---|---|---|---|---|
| Goal Achievement | 5 | 4 | Human | Both compute 54/1051 ≈ 5.1% and decline workup; human additionally audits likelihoods and refuses point precision |
| Logical Validity | 5 | 5 | tie | Arithmetic valid on both sides; divergence is what the numbers are permitted to mean |
| Coherence & Structure | 4 | 5 | AI | AI gated packet; human linear but disciplined |
| Depth of Reasoning | 5 | 3 | Human | Human audits likelihood provenance (enriched 100/100 cohort, single center, no CIs), full band 1.5%–5.1%; AI takes quoted Se/Sp as exact truth |
| Efficiency | 5 | 4 | Human | Human lines all load-bearing; AI spends lines on scaffolding |
| Handling of Uncertainty | 5 | 3 | Human | Human: unvalidated likelihoods → band, not point; AI: point estimate with spot checks presented as validated precision |
| Insight / Non-obviousness | 5 | 3 | Human | "The cohort was 50% cancer by construction; quoted numbers are hypotheses about likelihoods" — AI never questions the likelihoods |
| **Overall Quality** | **4.9** | **3.9** | **Human (clearly)** | Right decision number, overconfident status: SOLVED rests on unvalidated likelihoods treated as exact |

**Overall judgment:** Human clearly better. The AI reached the correct decision but with false precision — it audited the prior's reference class yet treated the manufacturer's development-cohort likelihoods as validated, reporting SOLVED where the honest answer is a band plus a validation demand.
